Invasive infections due to filamentous fungi other than Aspergillus: Epidemiology and determinants of mortality

Clinical Microbiology and Infection

Volumn 21, Issue 5, 2015, Pages 490.e1-490.e10

  Slavin, M ^a   van Hal, S ^b,c   Sorrell, T C ^d   Lee, A ^b   Marriott, D J ^e   Daveson, K ^f   Kennedy, K ^f   Hajkowicz, K ^g   Halliday, C ^h   Athan, E ⁱ   Bak, N ^j   Cheong, E ^k   Heath, C H ^l   Orla Morrissey, C ^m   Kidd, S ⁿ   Beresford, R ^o   Blyth, C ^o   Korman, T M ^m   Owen Robinson, J ^l,p   Meyer, W ^d,q   Chen, S C A ^d,h,q   Clark, J ^r   McCormack, J ^s   Looke, D ^t   Playford, E Geoffrey ^t   Gottlieb, T ^k   McMullan, B ^u   Ananda Rajah, M ^v   Macesic, N ^w   Thursky, K ^x   Arthur, I ^y   Morris, A ^z   Chambers, S ^aa   more..

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d University of Sydney   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f CANBERRA HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ DEAKIN UNIVERSITY   (Australia)

^j ROYAL ADELAIDE HOSPITAL   (Australia)

^k ANZAC Research Institute   (Australia)

^l ROYAL PERTH HOSPITAL   (Australia)

^m MONASH UNIVERSITY   (Australia)

ⁿ SA Pathology   (Australia)

^o UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^p CURTIN UNIVERSITY   (Australia)

^q UNIVERSITY OF SYDNEY   (Australia)

^r ROYAL CHILDREN'S HOSPITAL   (Australia)

^s MATER HOSPITAL   (Australia)

^t PRINCESS ALEXANDRA HOSPITAL   (Australia)

^u SYDNEY CHILDREN'S HOSPITAL   (Australia)

^v ALFRED HOSPITAL   (Australia)

^w Heidelberg   (Australia)

^x ROYAL MELBOURNE HOSPITAL   (Australia)

^y SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^z AUCKLAND CITY HOSPITAL   (New Zealand)

^aa CHRISTCHURCH HOSPITAL   (New Zealand)

more..

Author keywords

Determinants of outcome; Epidemiology; Filamentous fungus; Non Aspergillus moulds; Predisposing factors

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; ASPERGILLUS; AUSTRALIAN; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; FILAMENTOUS FUNGUS; FUNGUS CULTURE; FUSARIUM; GANODERMA; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INJURY; INTENSIVE CARE; LASIODIPLODIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MUCORMYCOSIS; MULTICENTER STUDY; MYCOSIS; NONHUMAN; OBSERVATIONAL STUDY; PAECILOMYCES; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; SCEDOSPORIUM; SURVIVAL; ADOLESCENT; AUSTRALIA; CHILD; CLASSIFICATION; CLINICAL TRIAL; FUNGEMIA; FUNGUS; ISOLATION AND PURIFICATION; MENINGITIS, FUNGAL; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SURGERY; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ASPERGILLUS; FUNGI; SCEDOSPORIUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; AUSTRALIA; CHILD; COMORBIDITY; FUNGEMIA; FUNGI; HUMANS; MALE; MENINGITIS, FUNGAL; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84930539837     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.12.021     Document Type: Article

References (38)

1. Ben-Ami R., Lewis R.E., Raad, Kontoyiannis D.P. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009, 48:1033-1041.
2. Park B.J., Pappas P.G., Wannemuehler K.A., Alexander B.D., Anaissie E.J., Andes D.R., et al. Invasive non-Aspergillus mould infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011, 17:1855-1864.
3. Husain S., Alexander B.D., Munoz P., Avery K., Houston S., Pruett T., et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003, 37:221-229.
4. Revankar S.G., Sutton D.A. Melanised fungi in human disease. Clin Microbiol Rev 2010, 23:884-928.
5. Heath C.H., Slavin M.A., Sorrell T.C., Handke R., Harun A., Phillips M., et al. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009, 15:689-693.
6. Tribble D.R., Warkentien T., Rodriguez C. Mucormycosis after a tornado in Joplin, Missouri. NEngl J Med 2013, 368:1067. Trauma Infectious Diseases Outcomes Study Group of the Infectious Disease Clinical Research Program.
7. Smith R.M., Schaefer M.K., Kainer M.A., Wise M., Finks J., Duwve J., et al. Fungal infections associated with contaminated methylprednisolone injections. NEngl J Med 2013, 369:1598-1609. Multistate Fungal Infection Outbreak Response Team.
8. Small K.W., Chan C.K., Silva-Garcia R., Walsh T.J. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Ophthalmology 2014, 121:952-958.
9. Slavin M.A., Chakrabarti A. Opportunistic fungal infections in the Asia-Pacific region. Med Mycol 2012, 50:18-25.
10. Schieffelin J.S., Garcia-Diaz J.B., Loss G.E., Beckman E.N., Keller R.A., Staffield-Coit C., et al. Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment. Transpl Infect Dis 2014, 16:270-278.
11. Qureshi Z.A., Kwak E.J., Nguyen M.H., Silveira F.P. Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients. Clin Transpl 2012, 26:e17-e23.
12. Samerpitak K., Van der Linde E., Choi H.-J., Gerrits Van den Ende A.H.C., Machouart M., Gueidan C., et al. Taxonomy of Ochroconis, genus including opportunistic pathogens on humans and animals. Fungal Diversity 2014, 65:89-126.
13. Giraud S., Favennec L., Bougnoux M.E., Bouchara J.P. Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance. Future Med 2013, 8:967-978.
14. De Ravin S.S., Challipalli M., Anderson V., Shea Y.R., Marciano B., Hilligoss D., et al. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis 2011, 52:e136-e143.
15. Pfaller M.A., Diekema D.J. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010, 36:1-53.
16. National Centre for Classification in Health International statistical classification of disease and related health problems, 10th revision. Australian modification (ICD-10-AM) 1998, The Centre, University of Sydney, Sydney.
17. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova T.A., Schaufele R.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41:634-653.
18. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
19. Lanternier F., Sun H.Y., Ribaud P., Singh N., Kontoyiannis D.P., Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012, 54:1629-1636.
20. Ciardo D.E., Lucke K., Imhof A., Bloemberg G.V., Böttger E.C. Systematic internal transcribed spacer sequence analysis for identification of clinical mould isolates in diagnostic mycology: a 5-year study. JClin Microbiol 2010, 48:2809-2813.
21. Kurtzman C.P., Robnett C.J. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. JClin Microbiol 1997, 35:1216-1223.
22. O'Donnell K., Sutton D.A., Rinaldi M.G., Sarver B.A., Balajee S.A., Schroers H.J., et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. JClin Microbiol 2010, 48:3708-3718.
23. Lau A., Chen S., Sorrell T., Carter D., Malik R., Martin P., et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. JClin Microbiol 2007, 45:380-385.
24. Tortorano A.M., Richardson M., Roilides E., van Diepeningen A., Caira M., Munoz P., et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 2014, 20(Suppl.3):27-46.
25. Pappas P.G., Alexander B.D., Andes D.R., Hadley S., Kauffman C.A., Freifeld A., et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010, 50:1101-1111.
26. Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., et al. Prospective surveillance for invasive fungal infections in haematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010, 50:1091-1100.
27. Ingram P.R., Suthananthan A.E., Rajan R., Pryce T.M., Sieunarine K., Gardam D.J., et al. Cutaneous mucormycosis and motor vehicle accidents: findings from an Australian case series. Med Mycol 2014, 52:819-825.
28. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695-704.
29. Delhaes L., Harun A., Chen S.C., Nguyen Q., Slavin M., Heath C.H., et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S.aurantiacum. Emerg Infect Dis 2008, 14:282-290.
30. Cortez K.J., Roilides E., Quiroz-Telles F., Meletiadis J., Antachopoulos C., Knudsen T., et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008, 21:157-197.
31. Blyth C.C., Middleton P.G., Harun A., Sorrell T.C., Meyer W., Chen S.C. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?. Med Mycol 2010, 48(Suppl.1):S37-S44.
32. Harun A., Gilgado F., Chen S.C., Meyer W. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonisation of airways in cystic fibrosis. Med Mycol 2010, 48(Suppl.1):S70-S76.
33. Koo S., Marty F.M., Baden L.R. Infectious complications associated with immunomodulating biologic agents. Haematol Oncol Clin North Am 2011, 25:117-138.
34. Pongas G.N., Lewis R.E., Samonis G., Kontoyiannis D.P. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?. Clin Microbiol Infect 2009, 15(Suppl.5):93-97.
35. Seyedmousavi S., Samerpitak K., Rijs A.J., Melchers W.J., Mouton J.W., Verweij P.E., et al. Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis. Antimicrob Agents Chemother 2014, 58:3285-3292.
36. Zhao Y., Petraitiene R., Walsh T.J., Perlin D.S. Areal-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. JClin Microbiol 2013, 51:1034-1036.
37. Litvintseva A.P., Lindsley M.D., Gade L., Smith R., Chiller T., Lyons J.L., et al. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis 2014, 58:622-630.
38. Chamilos G., Lewis R.E., Kontoyiannis D.P. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with haematologic malignancy who have zygomycosis. Clin Infect Dis 2008, 47:503-509.